ResMed Inc.
MX ˙ BMV ˙ US7611521078
SecurityMX:RMD / ResMed Inc.
InstitutionMAI Capital Management
Latest Disclosed Ownership3,431 shares
Latest Disclosed Value $ 770,258
MAI Capital Management reports 29.03% increase in ownership of RMD / ResMed Inc.

On May 15, 2026 - MAI Capital Management filed a 13F-HR form disclosing ownership of 3,431 shares of ResMed Inc. (MX:RMD) valued at $770,258 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 2,659 shares of ResMed Inc.. This represents a change in shares of 29.03% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F RESMED COM 761152107 3,431 772 29.03 770 20.31 0.0043
2026-02-13 2025-12-31 13F RESMED COM 761152107 2,659 -42 -1.55 640 -13.40 0.0037
2025-11-10 2025-09-30 13F RESMED COM 761152107 2,701 779 40.53 739 49.29 0.0046
2025-08-12 2025-06-30 13F RESMED COM 761152107 1,922 117 6.48 496 22.52 0.0034
2025-05-15 2025-03-31 13F RESMED COM 761152107 1,805 -59 -3.17 404 -5.16 0.0030
2025-02-14 2024-12-31 13F RESMED COM 761152107 1,864 -10 -0.53 426 -6.78 0.0032
2024-11-07 2024-09-30 13F ResMed CS 761152107 1,874 -327 -14.86 458 8.55 0.0044
2024-08-12 2024-06-30 13F ResMed CS 761152107 2,201 -372 -14.46 421 -17.29 0.0041
2024-05-08 2024-03-31 13F ResMed CS 761152107 2,573 1,007 64.30 510 89.22 0.0053
2024-02-09 2023-12-31 13F ResMed CS 761152107 1,566 -112 -6.67 269 8.47 0.0035
2023-11-14 2023-09-30 13F ResMed CS 761152107 1,678 -228 -11.96 248 -40.38 0.0037
2023-08-02 2023-06-30 13F ResMed CS 761152107 1,906 102 5.65 417 5.32 0.0061
2023-05-10 2023-03-31 13F ResMed CS 761152107 1,804 -860 -32.28 395 -28.70 0.0062
2023-02-09 2022-12-31 13F ResMed CS 761152107 2,664 8 0.30 554 -4.48 0.0093
2022-11-15 2022-09-30 13F ResMed CS 761152107 2,656 -8,255 -75.66 580 -74.64 0.0109
2022-07-19 2022-06-30 13F ResMed CS 761152107 10,911 -84 -0.76 2,287 -14.22 0.0437
2022-05-10 2022-03-31 13F ResMed CS 761152107 10,995 -129 -1.16 2,666 -8.01 0.0448
2022-02-11 2021-12-31 13F ResMed CS 761152107 11,124 852 8.29 2,898 7.06 0.0467
2021-11-12 2021-09-30 13F ResMed CS 761152107 10,272 23 0.22 2,707 7.12 0.0521
2021-07-19 2021-06-30 13F ResMed CS 761152107 10,249 -995 -8.85 2,527 15.81 0.0502
2021-05-10 2021-03-31 13F ResMed CS 761152107 11,244 127 1.14 2,182 -7.66 0.0488
2021-02-16 2020-12-31 13F ResMed CS 761152107 11,117 -244 -2.15 2,363 21.30 0.0591
2020-10-26 2020-09-30 13F ResMed CS 761152107 11,361 -1,701 -13.02 1,948 -22.33 0.0564
2020-07-27 2020-06-30 13F ResMed CS 761152107 13,062 -1,518 -10.41 2,508 16.81 0.0787
2020-04-16 2020-03-31 13F ResMed CS 761152107 14,580 875 6.38 2,147 1.08 0.0876
2020-02-03 2019-12-31 13F ResMed CS 761152107 13,705 -2,195 -13.81 2,124 -1.12 0.0688
2019-10-29 2019-09-30 13F ResMed CS 761152107 15,900 307 1.97 2,148 12.87 0.0957
2019-08-15 2019-06-30 13F ResMed CS 761152107 15,593 6,593 73.26 1,903 103.31 0.0860
2019-04-29 2019-03-31 13F ResMed CS 761152107 9,000 -650 -6.74 936 -14.83 0.0479
2019-01-30 2018-12-31 13F ResMed CS 761152107 9,650 -320 -3.21 1,099 -4.43 0.0641
2018-10-12 2018-09-30 13F ResMed CS 761152107 9,970 -380 -3.67 1,150 7.28 0.0587
2018-08-16 2018-06-30 13F ResMed CS 761152107 10,350 -1,435 -12.18 1,072 -7.59 0.0578
2018-04-17 2018-03-31 13F ResMed CS 761152107 11,785 -1,675 -12.44 1,160 1.75 0.0659
2018-01-30 2017-12-31 13F ResMed CS 761152107 13,460 10 0.07 1,140 10.14 0.0648
2017-10-12 2017-09-30 13F ResMed CS 761152107 13,450 -25 -0.19 1,035 -1.33 0.0628
2017-08-07 2017-06-30 13F ResMed CS 761152107 13,475 -590 -4.19 1,049 3.66 0.0676
2017-05-11 2017-03-31 13F ResMed CS 761152107 14,065 265 1.92 1,012 18.22 0.0681
2017-01-31 2016-12-31 13F ResMed CS 761152107 13,800 0 0.00 856 -4.25 0.0622
2016-10-18 2016-09-30 13F ResMed CS 761152107 13,800 -250 -1.78 894 0.68 0.0674
2016-07-14 2016-06-30 13F ResMed CS 761152107 14,050 -375 -2.60 888 6.47 0.0684
2016-04-08 2016-03-31 13F ResMed CS 761152107 14,425 14,425 834 0.0638
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.